PMID: 9423721Jan 10, 1998Paper

A novel protamine variant reversal of heparin anticoagulation in human blood in vitro

Journal of Vascular Surgery
M S HulinJ C Stanley

Abstract

Protamine reversal of heparin anticoagulation during cardiovascular surgery may cause severe hypotension and pulmonary hypertension. A novel protamine variant, [+18RGD], has been developed that effectively reverses heparin anticoagulation without toxicity in canine experiments. Heretofore, human studies have not been undertaken. This investigation hypothesized that [+18RGD] would effectively reverse heparin anticoagulation of human blood in vitro. Fifty patients who underwent anticoagulation therapy during vascular surgery had blood sampled at baseline and 30 minutes after receiving heparin (150 IU/kg). Activated clotting times were used to define specific quantities of [+18RGD] or protamine necessary to completely reverse heparin anticoagulation in the blood sample of each patient. These defined amounts of [+18RGD] or protamine were then administered to the heparinized blood samples, and percent reversals of activated partial thromboplastin time, thrombin clotting time, and antifactor Xa/IIa levels were determined. In addition, platelet aggregation assays, as well as platelet and white blood cell counts were performed. [+18RGD] and protamine were equivalent in reversing heparin as assessed by thrombin clotting time, antifactor...Continue Reading

References

May 30, 1991·The New England Journal of Medicine·J Hirsh
Sep 1, 1995·Journal of Vascular Surgery·M C MauneyI L Kron
Jun 1, 1994·The Journal of Surgical Research·T W WakefieldJ C Stanley
Apr 1, 1997·The Journal of Thoracic and Cardiovascular Surgery·H HabazettlP Conzen
Apr 1, 1997·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·S J FearnC N McCollum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.